Dimensional Fund Advisors
PMD

Dimensional Fund Advisors’s Psychemedics Corporation PMD Stock Holding History

Dimensional Fund Advisors’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,060
Closed -$48.6K – 3380
2024
Q3 		$48.6K Sell
21,060
-1,628
-7% -$3.66K ﹤0.01% 3302
2024
Q2 		$54.9K Sell
22,688
-13,429
-37% -$34.1K ﹤0.01% 3304
2024
Q1 		$106K Hold
36,117
– – ﹤0.01% 3255
2023
Q4 		$107K Sell
36,117
-2,067
-5% -$5.51K ﹤0.01% 3273
2023
Q3 		$152K Sell
38,184
-17,971
-32% -$80.2K ﹤0.01% 3257
2023
Q2 		$256K Sell
56,155
-407
-0.7% -$2.06K ﹤0.01% 3195
2023
Q1 		$297K Sell
56,562
-2,354
-4% -$13K ﹤0.01% 3124
2022
Q4 		$290 Buy
58,916
+190
+0.3% +$1.12K ﹤0.01% 3148
2022
Q3 		$379K Sell
58,726
-1,103
-2% -$7.09K ﹤0.01% 3103
2022
Q2 		$379K Sell
59,829
-478
-0.8% -$3.06K ﹤0.01% 3127
2022
Q1 		$419K Sell
60,307
-2,351
-4% -$16.6K ﹤0.01% 3188
2021
Q4 		$435K Sell
62,658
-13,523
-18% -$108K ﹤0.01% 3198
2021
Q3 		$648K Sell
76,181
-38,442
-34% -$282K ﹤0.01% 3129
2021
Q2 		$798K Buy
114,623
+7,423
+7% +$52K ﹤0.01% 3077
2021
Q1 		$665K Sell
107,200
-8,261
-7% -$54.7K ﹤0.01% 3085
2020
Q4 		$588K Sell
115,461
-7,151
-6% -$31K ﹤0.01% 3067
2020
Q3 		$541K Sell
122,612
-23,409
-16% -$114K ﹤0.01% 3042
2020
Q2 		$803K Hold
146,021
– – ﹤0.01% 2993
2020
Q1 		$883K Sell
146,021
-2,262
-2% -$19.1K ﹤0.01% 2939
2019
Q4 		$1.36M Buy
148,283
+7,430
+5% +$68.6K ﹤0.01% 2952
2019
Q3 		$1.28M Buy
140,853
+1,500
+1% +$12.7K ﹤0.01% 2958
2019
Q2 		$1.41M Buy
139,353
+6,216
+5% +$70.5K ﹤0.01% 2982
2019
Q1 		$1.87M Buy
133,137
+1,600
+1% +$27.5K ﹤0.01% 2910
2018
Q4 		$2.09M Sell
131,537
-533
-0.4% -$9.19K ﹤0.01% 2862
2018
Q3 		$2.48M Buy
132,070
+1,515
+1% +$30.2K ﹤0.01% 2868
2018
Q2 		$2.51M Buy
130,555
+603
+0.5% +$12.2K ﹤0.01% 2835
2018
Q1 		$2.69M Buy
129,952
+5,523
+4% +$115K ﹤0.01% 2803
2017
Q4 		$2.56M Buy
124,429
+4,650
+4% +$86.3K ﹤0.01% 2805
2017
Q3 		$2.21M Buy
119,779
+14,256
+14% +$314K ﹤0.01% 2835
2017
Q2 		$2.63M Buy
105,523
+13,078
+14% +$275K ﹤0.01% 2788
2017
Q1 		$1.85M Buy
92,445
+12,860
+16% +$282K ﹤0.01% 2858
2016
Q4 		$1.96M Buy
79,585
+19,573
+33% +$439K ﹤0.01% 2827
2016
Q3 		$1.19M Buy
60,012
+9,106
+18% +$169K ﹤0.01% 2900
2016
Q2 		$699K Buy
50,906
+2,577
+5% +$35.8K ﹤0.01% 2994
2016
Q1 		$665K Buy
48,329
+810
+2% +$9.29K ﹤0.01% 2999
2015
Q4 		$482K Hold
47,519
– – ﹤0.01% 3099
2015
Q3 		$479K Buy
47,519
+800
+2% +$9.32K ﹤0.01% 3125
2015
Q2 		$693K Buy
46,719
+1,980
+4% +$30.8K ﹤0.01% 3085
2015
Q1 		$743K Hold
44,739
– – ﹤0.01% 3046
2014
Q4 		$674K Sell
44,739
-365
-0.8% -$5.3K ﹤0.01% 3088
2014
Q3 		$642K Hold
45,104
– – ﹤0.01% 3110
2014
Q2 		$639K Sell
45,104
-400
-0.9% -$6.08K ﹤0.01% 3138
2014
Q1 		$779K Hold
45,504
– – ﹤0.01% 3092
2013
Q4 		$668K Sell
45,504
-1,900
-4% -$26.1K ﹤0.01% 3124
2013
Q3 		$628K Sell
47,404
-2,350
-5% -$29.2K ﹤0.01% 3144
2013
Q2 		$534K Buy
+49,754
New +$559K ﹤0.01% 3160

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Dimensional Fund Advisors's PMD Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 21,060 shares — an estimated $48.6K sold.

Dimensional Fund Advisors first reported a position in PMD in Q2 2013 and held it in 46 quarters. The position peaked at $2.69M in Q1 2018. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 21,060 Psychemedics Corporation shares in Q4 2024, an estimated $48.6K.
  • Dimensional Fund Advisors first reported a position in Psychemedics Corporation in Q2 2013 and held it in 46 quarters.
  • Dimensional Fund Advisors's Psychemedics Corporation position peaked at $2.69M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.